Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say

According to statements from Democrats, investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year. The portfolio reportedly added millions of dollars in stock holdings.

The targeted firms include companies that benefited from Medicare exemptions, raising questions regarding the intersection of presidential investments and public policy decisions.